Wed, January 2, 2013
[ Wed, Jan 02nd 2013 ]: Market Wire
IBEX Acquires Bio-Research Products, Inc.
[ Wed, Jan 02nd 2013 ]: Market Wire
Merus Labs International Inc. Announces Results for Fiscal 2012
[ Wed, Jan 02nd 2013 ]: Market Wire
USPTO Grants Quick-Med Tenth U.S. Patent for NIMBUS(R) Technology
[ Wed, Jan 02nd 2013 ]: Market Wire
Stellar Pharmaceuticals Announces Name &;&# .. Pharmaceuticals Canada Inc. and 'TBUFF';;
[ Wed, Jan 02nd 2013 ]: Market Wire
Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference on January 7, 2013
[ Wed, Jan 02nd 2013 ]: Market Wire
Isis Pharmaceuticals To Present At The 31st Annual J.P. Morgan Healthcare Conference
[ Wed, Jan 02nd 2013 ]: Market Wire
BioLife Solutions To Present at OneMedForum 2013
Mon, December 31, 2012
[ Mon, Dec 31st 2012 ]: Market Wire
Quest Diagnostics Sells OralDNA Labs to Access Genetics
[ Mon, Dec 31st 2012 ]: Market Wire
Mindray to Participate in Upcoming Investor Conferences and Events
Fri, December 28, 2012
[ Fri, Dec 28th 2012 ]: Market Wire
Mylan Launches Generic Dilantin Chewable Tablets
[ Fri, Dec 28th 2012 ]: Market Wire
Mylan Launches Generic Nordette 28 Tablets
[ Fri, Dec 28th 2012 ]: Market Wire
Perrigo Company Acquires Remaining Stake In Cobre .. armaceuticals, Inc. For Approximately $45 Million
[ Fri, Dec 28th 2012 ]: Market Wire
Watson Confirms Velcade Patent Challenge
[ Fri, Dec 28th 2012 ]: Market Wire
EmergingGrowth.com Special Report on RVPlus, Inc. .. Gas, and Patents infringement in Pharmaceuticals
[ Fri, Dec 28th 2012 ]: Market Wire
Sarepta Therapeutics to Present Company Overview .. 2013 31st Annual JP Morgan Healthcare Conference
[ Fri, Dec 28th 2012 ]: Market Wire
Aeterna Zentaris Granted Special Protocol Assessm .. gistration Trial in Endometrial Cancer with AEZS-
Thu, December 27, 2012
[ Thu, Dec 27th 2012 ]: Market Wire
MGC Diagnostics Corporation to Present at the Sid .. k Micro Cap Conference on Monday, January 7, 2013
[ Thu, Dec 27th 2012 ]: Market Wire
Abattis Amends License Agreement with Vertical De .. sive, Worldwide Rights to Bio-Pharma Patent Licen
[ Thu, Dec 27th 2012 ]: Market Wire
PAREXEL International Announces Acquisition of Liquent, Inc., and Updates Financial Guidance
[ Thu, Dec 27th 2012 ]: Market Wire
Herbalife, Bank of America, Hovnanian Enterprises, General Electric, AT&T, and Citigroup
[ Thu, Dec 27th 2012 ]: Market Wire
University of North Carolina Hospitals Standardiz .. SET Pulse Oximetry for Improved Patient Outcomes
[ Thu, Dec 27th 2012 ]: Market Wire
U.S. Food and Drug Administration Accepts XIAFLEX .. se Application Filing for the Treatment of Peyron
[ Thu, Dec 27th 2012 ]: Market Wire
China Cord Blood Corporation Announces Participat .. the 31st Annual J.P. Morgan Healthcare Conference
Wed, December 26, 2012
[ Wed, Dec 26th 2012 ]: Market Wire
Cardica Begins Shipping MicroCutter XCHANGEa" 30 Commercial Units For Europe
[ Wed, Dec 26th 2012 ]: Market Wire
Echo Therapeutics Announces Full Exercise of Over-Allotment Option
[ Wed, Dec 26th 2012 ]: Market Wire
Depomed Announces Dismissal Of Suit Against Two G .. Following Withdrawal Of ANDA And Patent Challenge
[ Wed, Dec 26th 2012 ]: Market Wire
BD Completes Acquisition of Safety Syringes, Inc.
[ Wed, Dec 26th 2012 ]: Market Wire
MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
Mon, December 24, 2012
[ Mon, Dec 24th 2012 ]: Market Wire
Orexigen Therapeutics Announces Webcast of Upcomi .. esentation at the JP Morgan Healthcare Conference
[ Mon, Dec 24th 2012 ]: Market Wire
Concord Medical Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
Fri, December 21, 2012
[ Fri, Dec 21st 2012 ]: Market Wire
ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction
[ Fri, Dec 21st 2012 ]: Market Wire
Sarepta Therapeutics Enters Into Clinical Trial A .. stitutes of Health for Further Development of Inf
[ Fri, Dec 21st 2012 ]: Market Wire
Johnson & Johnson to Host Analyst Meeting to Disc .. 2012 Financial Results and Medical Devices and Di
[ Fri, Dec 21st 2012 ]: Market Wire
Venaxis Files for CE Mark and Prepares for European Commercialization
[ Fri, Dec 21st 2012 ]: Market Wire
Horizon Pharma to Receive Approval of DUEXIS(R) F .. edicines and Healthcare Products Regulatory Agenc
[ Fri, Dec 21st 2012 ]: Market Wire
Biostar Pharmaceuticals, Inc. Commences Call Center Operations
Thu, December 20, 2012
[ Thu, Dec 20th 2012 ]: Market Wire
A Year Of Taking Action
[ Thu, Dec 20th 2012 ]: Market Wire
Omni Bio Pharmaceutical Appoints New CEO
[ Thu, Dec 20th 2012 ]: Market Wire
Acura Pharmaceuticals, Inc. Submits Investigational New Drug Application
[ Thu, Dec 20th 2012 ]: Market Wire
The Medicines Company Announces Positive Trial Re .. Treatment of Acute Bacterial Skin and Skin Struct
[ Thu, Dec 20th 2012 ]: Market Wire
Implant Sciences Expands Global Aviation Security .. resence as It Ships More Quantum Sniffers to Asia
[ Thu, Dec 20th 2012 ]: Market Wire
VIVUS Announces Express Scripts Adds Qsymia (Phen .. ed-Release) Capsules CIV To Its Standard Benefits
Wed, December 19, 2012
[ Wed, Dec 19th 2012 ]: Market Wire
Shoal Point Energy Signs a Letter of Intent for a .. Develop Its Green Point Shale Licenses, West New
[ Wed, Dec 19th 2012 ]: Market Wire
LED Medical Diagnostics Announces Non-Brokered Expedited Private Placement
[ Wed, Dec 19th 2012 ]: Market Wire
Endo Health Solutions Comments on Dismissal of Suit Against FDA
[ Wed, Dec 19th 2012 ]: Market Wire
Sanofi US Reaches Settlement Agreement on Hyalgan
[ Wed, Dec 19th 2012 ]: Market Wire
Amgen Finalizes Agreement Resolving Previously Announced Federal Investigations
[ Wed, Dec 19th 2012 ]: Market Wire
Global Green, Inc. Announces Trial Studies Indica .. f Salmogenics May Improve Performance of Broilers

Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the JP Morgan Healthcare Conference

Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the JP Morgan... -- SAN DIEGO, Calif., Dec. 24, 2012 /PRNewswire/ --

SAN DIEGO, Calif., Dec. 24, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will present a company overview at the JP Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Tuesday, January 8, 2013 at 10:30 a.m. Pacific Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at [ www.orexigen.com ]. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

Orexigen Contact:

Media Contact: 

McDavid Stilwell

Denise Powell

VP, Corporate Communications and Business Development

WCG

(858) 875-8629

(510) 703-9491

SOURCE Orexigen Therapeutics, Inc.



RELATED LINKS
[ http://www.orexigen.com ]